Is the BTS/SIGN guideline confusing? A retrospective database analysis of asthma therapy

Primary Care Respiratory Journal

Volumn 22, Issue 3, 2013, Pages 290-295

  Covvey, Jordan R ^a   Johnston, Blair F ^a   Wood, Fraser ^b   Boyter, Anne C ^a  

^a UNIVERSITY OF STRATHCLYDE   (United Kingdom)

^b FORTH VALLEY ROYAL HOSPITAL   (United Kingdom)

Author keywords

Asthma guideline; General practice; Prescribing patterns; Retrospective cohort

Indexed keywords

BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; CORTICOSTEROID; LONG ACTING DRUG; SHORT ACTING DRUG; THEOPHYLLINE;

ADULT; AGE DISTRIBUTION; ARTICLE; ASTHMA; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL EVALUATION; COMORBIDITY; DATA ANALYSIS; DISEASE SEVERITY; DOSE RESPONSE; DRUG MEGADOSE; DRUG UTILIZATION; FEMALE; HUMAN; LOW DRUG DOSE; MAJOR CLINICAL STUDY; MALE; MEDICAL SOCIETY; MONOTHERAPY; PATIENT CODING; POPULATION RESEARCH; PRACTICE GUIDELINE; RETROSPECTIVE STUDY; SEX DIFFERENCE; SMOKING; STEROID THERAPY; TREATMENT OUTCOME;

ADMINISTRATION, INHALATION; ADMINISTRATION, ORAL; ADRENAL CORTEX HORMONES; ADRENERGIC BETA-2 RECEPTOR AGONISTS; ADULT; AGE FACTORS; AGED; ASTHMA; COHORT STUDIES; DATABASES, FACTUAL; DRUG THERAPY, COMBINATION; FEMALE; GREAT BRITAIN; GUIDELINE ADHERENCE; HUMANS; MALE; MIDDLE AGED; PHYSICIAN'S PRACTICE PATTERNS; PRACTICE GUIDELINES AS TOPIC; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RETROSPECTIVE STUDIES; SEX FACTORS; SMOKING;

EID: 84883449597     PISSN: 14714418     EISSN: 14751534     Source Type: Journal    
DOI: 10.4104/pcrj.2013.00060     Document Type: Article

References (20)

1. British Thoracic Society and Scottish Intercollegiate Guidelines Network (SIGN). British guideline on the management of asthma. A national clinical guideline. (SIGN publication no. 101). http://www.sign.ac.uk/guidelines/fulltext/101/index.html (accessed 10 Sep 2012).
2. Guidelines for management of asthma in adults: I-Chronic persistent asthma. Statement by the British Thoracic Society, Research Unit of the Royal College of Physicians of London, King's Fund Centre, National Asthma Campaign. BMJ 1990;301:651-3. http://dx.doi.org/10.1136/bmj.301.6753.651
3. British Thoracic Society, British Paediatric Association, Royal College of Physicians of London, et al. Guidelines on the management of asthma. Thorax 1993;48(Suppl 2):S1-24.
4. British Thoracic Society and Scottish Intercollegiate Guidelines Network. British guideline on the management of asthma. Thorax 2003;58(Suppl 1):i1-94.
5. Global Initiative for Asthma (GINA). Global strategy for asthma management and prevention. 2012. http://www.ginasthma.org/ (accessed 28 Jan 2013).
6. National Heart, Lung and Blood Institute (NHLBI). National Asthma Education and Prevention Program (NAEPP). Expert Panel Report 3 (EPR3): Guidelines for the diagnosis and management of asthma. 2007. http://www.nhlbi.nih.gov/guidelines/asthma/asthgdln.pdf (accessed 28 Jan 2013).
7. Greening AP, Ind PW, Northfield M, Shaw G. Added salmeterol versus higher-dose corticosteroid in asthma patients with symptoms on existing inhaled corticosteroid. Allen & Hanburys Limited UK Study Group. Lancet 1994;344:219-24. http://dx.doi.org/10.1016/S0140-6736(94)92996-3
8. Shrewsbury S, Pyke S, Britton M. Meta-analysis of increased dose of inhaled steroid or addition of salmeterol in symptomatic asthma (MIASMA). BMJ 2000;320:1368-73. http://dx.doi.org/10.1136/bmj.320.7246.1368
9. Masoli M, Weatherall M, Holt S, Beasley R. Moderate dose inhaled corticosteroids plus salmeterol versus higher doses of inhaled corticosteroids in symptomatic asthma. Thorax 2005;60:730-4. http://dx.doi.org/10.1136/thx.2004.039180
10. Pauwels RA, Löfdahl CG, Postma DS, et al. Effect of inhaled formoterol and budesonide on exacerbations of asthma. Formoterol and Corticosteroids Establishing Therapy (FACET) International Study Group. N Engl J Med 1997;337:1405-11. http://dx.doi.org/10.1056/NEJM199711133372001
11. Neville RG, Pearson MG, Richards N, et al. A cost analysis on the pattern of asthma prescribing in the UK. Eur Respir J 1999;14:605-09. http://dx.doi.org/10.1034/j.1399-3003.1999.14c20.x
12. ©. E-PRS. http://www.campbellsoftware.co.uk/products/gskcdm/ (accessed 10 Sept 2012).
13. Reddel HK, Taylor DR, Bateman ED, et al; American Thoracic Society/European Respiratory Society Task Force on Asthma Control and Exacerbations. An official American Thoracic Society/European Respiratory Society statement: asthma control and exacerbations: standardizing endpoints for clinical asthma trials and clinical practice. Am J Respir Crit Care Med 2009;180(1):59-99. http://dx.doi.org/10.1164/rccm.200801-060ST
14. Ducharme FM, Ni Chroinin M, Greenstone I, Lasserson TJ. Addition of long-acting beta2-agonists to inhaled corticosteroids versus same dose inhaled corticosteroids for chronic asthma in adults and children. Cochrane Database Syst Rev 2010; (5):CD005535. http://dx.doi.org/10.1002/14651858.CD005535.pub2
15. Thomas M, von Ziegenweidt J, Lee AJ, Price D. High-dose inhaled corticosteroids versus add-on long-acting β-agonists in asthma: an observational study. J Allergy Clin Immunol 2009;123:116-21. http://dx.doi.org/10.1016/j.jaci.2008.09.035
16. Sears MR. The addition of long-acting beta-agonists to inhaled corticosteroids in asthma. Curr Opin Pulm Med 2011;17(1):23-8. http://dx.doi.org/10.1097/MCP.0b013e328341004c
17. Haughney J, Price D, Kaplan A, et al. Achieving asthma control in practice: understanding the reasons for poor control. Respir Med 2008;102(12):1681-93. http://dx.doi.org/10.1016/j.rmed.2008.08.003
18. Electronic Medicines Compendium. Seretide 100, 250, 500 Accuhaler. http://www.medicines.org.uk/emc/medicine/2317/SPC/ (accessed 29 Jan 2012).
19. Electronic Medicines Compendium. Symbicort Turbohaler 400/12, Inhalation powder. http://www.medicines.org.uk/emc/medicines/11882/SPC/ (accessed 29 Jan 2012).
20. NHS Scotland. Prescribing Information System for Scotland (PRISMS). http://www.isdscotland.org/Health-Topics/Prescribing-and-Medicines/PRISMS/ (accessed 15 Aug 2012).